Literature DB >> 16898531

[Evaluation of arterial intima-media thickness (IMT) in children with idiopathic nephrotic syndrome--preliminary report].

Joanna Ksiazek1, Anna Niemirska, Maria Lipka, Ryszard Grenda.   

Abstract

UNLABELLED: One the complications of idiopathic nephrotic syndrome (i.n.s.) is long-lasting lipid unfavourable lipid profile, a risk factor of early atherosclerosis. Aim of the study was evaluation of the incidence of early signs of atheromathosis in children with INS expressed as the increased IMT in the (elastic) common carotid (cIMT) and (muscular) superficial femoral ((fIMT) arteries. The study included 50 children (34 boys and 16 girls) aged from 5.83 to 16.58 y (mean 10,8) with INS Overall duration of the disease ranged from 2.58 to 13.83 y (mean 7.81) [in 23 (46%) children < 10 yrs mean 6.21 yrs; in 16 (32%) from 10 to 14 yrs mean 11.93 yrs and in 11 (22%) >14 yrs mean 4.27 yrs]. 16 children were treated with prednisone, 32 with cyclosporine A (CsA) and 2 mycophenolate mofetil (MMF). The renal function in 49 children was normal and decreased in 1 case. Children treated with CsA and MMF received renoprotection with enalapril or enalapril/losartan. USG technique was used to evaluate cIMT and fIMT. In 39 (78%) pts, 26/34 (76.47%) > and 13/16 (81.25%) + cIMT was increased. fIMT was increased in 13 (26%) pts, including 12/34 (35.29%) > and 1/16 (6.25%) +. Among pts <10y. of age cIMT was increased in 19/23 (82.6%) and fIMT in 5/23 (21.73%). Among pts between 10-14 yrs cIMT was increased in 13/16 (81.25%), and fIMT in 4/16 (25%). Among pts >14 yrs cIMT was increased in 7/11 (63.63%), and fIMT in 4 (36,36%) cases.
CONCLUSION: Increased intima-media thickness in (elastic) carotid artery was shown in vast majority of children with nephrotic syndrome.

Entities:  

Mesh:

Year:  2006        PMID: 16898531

Source DB:  PubMed          Journal:  Przegl Lek        ISSN: 0033-2240


  5 in total

1.  Effect of atorvastatin on dyslipidemia and carotid intima-media thickness in children with refractory nephrotic syndrome: a randomized controlled trial.

Authors:  Pankaj Hari; Priyanka Khandelwal; Amit Satpathy; Smriti Hari; Ranjeet Thergaonkar; R Lakshmy; Aditi Sinha; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2018-08-08       Impact factor: 3.714

2.  Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome.

Authors:  Maria H Kniazewska; Anna K Obuchowicz; Tomasz Wielkoszyński; Joanna Zmudzińska-Kitczak; Katarzyna Urban; Marta Marek; Jolanta Witanowska; Karolina Sieroń-Stołtny
Journal:  Pediatr Nephrol       Date:  2008-10-30       Impact factor: 3.714

3.  Carotid intima media thickness in children with nephrotic syndrome: an observational case control study.

Authors:  Anita Mehta; Shambhavi Mishra; Kaleem Ahmad; Harish Chandra Tiwari; Vijay Singh; Abhishek Singh
Journal:  Sudan J Paediatr       Date:  2019

4.  Subclinical cardiovascular disease and its association with risk factors in children with steroid-resistant nephrotic syndrome.

Authors:  Cengiz Candan; Nur Canpolat; Selman Gökalp; Nurdan Yıldız; Pınar Turhan; Mehmet Taşdemir; Lale Sever; Salim Çalışkan
Journal:  Pediatr Nephrol       Date:  2013-09-15       Impact factor: 3.714

Review 5.  Treating the idiopathic nephrotic syndrome: are steroids the answer?

Authors:  Georges Deschênes; Claire Dossier; Julien Hogan
Journal:  Pediatr Nephrol       Date:  2018-06-04       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.